Are 16-75 years old
A Clinical Study for People with Crohn's Disease
If you or a loved one has Crohn's disease, you may be eligible to participate in the ARES-CD clinical research study.
About the Study
What is the
ARES-CD Clinical Study?
Researchers are evaluating an investigational medication to assess its safety and effectiveness in individuals with moderately to severely active Crohn’s disease. The study aims to expand treatment options, and eligible participants may receive study-related care at no cost.
Open to individuals aged 16-75 with Crohn's disease.
Participants must have had Crohn's disease for at least 3 months.
Study involves IV infusions and subcutaneous injections.
All study-related care and medication are provided at no cost.
Compensation may be available for study-related travel expenses.
Eligibility Criteria
Who Can Participate?
You may qualify if you:
What to Expect
What's Involved in the Study?
All medical tests and investigational study medicine will be provided at no cost.
Frequently Asked Questions
What is an investigational study medicine?
It is a medication being tested for safety and effectiveness but has not yet been approved for general use.
Will l receive a placebo?
Some participants may receive a placebo during certain study phases, but all eligible participants in the optional extension period will receive the investigational medication.
Do l have to pay for study participation?
No, all study-related care, medication, and medical tests are provided at no cost.
Will l be reimbursed for travel?
Yes, compensation may be available for study-related travel expenses.
Apply to
Join the Study
To learn more about the study, check eligibility, or participate, click on your preferred location below and complete the form on that page.